Direct Answer

Pfizer reports revenue across 3 geographic regions in its fiscal 2025 Form 10-K. United States is the largest, with $37.1 billion of revenue (59% of the total), followed by International Developed Markets at $16.2 billion (26%). 59% of revenue came from the United States.

How Does Pfizer Make Money?

No single region supplies a majority of revenue: the largest, United States, is 59%, which spreads Pfizer's exposure across several demand drivers. Between fiscal 2024 and 2025, International Emerging Markets grew fastest (+4.9%) and United States slowest (-4.2%), so the revenue mix tilts toward International Emerging Markets while that gap lasts.

RegionFY2025 revenueFY2024 revenueShare of revenueChange
United States$37.1 billion$38.7 billion59.2%-4.2%
International Developed Markets$16.2 billion$16.1 billion25.9%0.8%
International Emerging Markets$9.3 billion$8.9 billion14.9%4.9%
Bar chart of Pfizer revenue by region for fiscal 2025: United States 59.2%, International Developed Markets 25.9%, International Emerging Markets 14.9%.
Pfizer revenue by region as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.

What the Segment Figures Do Not Show

The rows above add up to 100% of Pfizer's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

Where These Numbers Come From

Every figure on this page is a value Pfizer reported in the segment note and revenue disclosures of its Form 10-K filed February 26, 2026 (accession 0000078003-26-000026), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

Frequently Asked Questions

What are Pfizer's main regions?

In its fiscal 2025 Form 10-K, Pfizer reports revenue for United States, International Developed Markets and International Emerging Markets.

Which part of Pfizer brings in the most revenue?

United States, with $37.1 billion of revenue in fiscal 2025, or 59% of the total.

How much of Pfizer's revenue comes from outside the United States?

41% in fiscal 2025, by the geographic breakdown Pfizer reports in its Form 10-K. Companies assign revenue to regions differently (customer location, shipping address or selling entity), so check the filing's definition before comparing companies.

References

Related Pages